medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2016, Number 2

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2016; 32 (2)

Hybridization patterns of BCR/ABL1 gen in cuban patients with leukemia

Hernández AN, Lavaut SK, Ruiz MV

Language: Spanish
References: 15
Page: 215-222
PDF size: 173.75 Kb.


ABSTRACT

Introduction: Chronic myeloid leukemia (CML) is characterized by the t(9;22) translocation resulting in the formation of BCR/ABL1 fusion gen. Sometimes this genetic alteration can be associated to deletions in sequences of derivative chromosome 9 and other variants detected by fluorescence in situ hybridization (FISH) technique.
Objective: To describe hybridization patterns in patients positive to t(9;22) after the introduction of FISH at the leukemia study in Cuba.
Methods: The bone marrow samples of 36 patients with diagnosis of CML and eight patients with acute lymphoblastic leukemia (ALL) were studied at the Cytogenetics Laboratory of the Institute of Hematology and Immunology. The BCR/ABL Dual Color Dual Fusion probe was used.
Results: The sample of two CML patients were non-useful for diagnosis and 18 were t(9;22) positive, one with an atypical pattern of signals. All the ALL patients were negative. In one negative CML patient was observed a pattern of signals suggestive of trisomy 9.
Conclusions: Incorporation of FISH for the BCR/ABL1 transcript study in CML and ALL patients allowed us to detect its presence and the existence of different patterns of signals which could be no detectable by conventional cytogenetic and could have prognostic significance.


REFERENCES

  1. Comert M, Baran Y, Saydam G. Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor era. Am J Blood Res. 2013; 3(3): 191-200.

  2. Cetin Z, Yakut S, Karadogan I, Kupesiz A, Timuragaoglu A, Salim O et al. Aberrations of chromosomes 9 and 22 in acute lymphoblastic leukemia cases detected by ES-fluorescence in situ hybridization. Genet Test Mol Biomarkers. 2012 May; 16(5): 318-23.

  3. Lee DS, Lee YS, Yun YS, Kim YR, Jeong SS, Lee YK et al. A Study on the Incidence of ABL Gene Deletion on Derivative Chromosome 9 in Chronic Myelogenous Leukemia by Interphase Fluorescence In Situ Hybridization and Its Association With Disease Progression. Genes Chromosomes Cancer. 2003 Jul; 37(3):291-9.

  4. Espinet B, Salido M, Solé F. Técnicas de citogenética molecular y sus aplicaciones. Utilidad de la citogenética en el estudio de las neoplasias. Laboratori de Citogenètica i Biologia Molecular. Servei de Patologia. Hospital de Mar de Barcelona. (citado junio 30,2015).Disponible en: http://www.seapcongresos.com/2005/Cursos/Curso_Largo_Patologia_Molecular/Citog enetica_molecular.PDF .

  5. Solé F. Bases técnicas del FISH. Servei de Patologia. Laboratori de Citogenètica i Biologia Molecular Hospital del Mar. Barcelona. (citado junio 30,2015) (Disponible en: https://www.seap.es/c/document_library/get_file?uuid=065873b3-02a9-452f-9b49- 605a3ebcbddd&groupId=10157 )

  6. Jardan C, Jardan D, Coriu D, Severin E. Atypical patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in patients with chronic myeloid leukemia. Revista Român ă de Medicină de Laborator. 2012 Sept; 20(3/4):255-63.

  7. Esan OA,Senft JR, Wenger SL. Patterns of BCR/ABL Gene Rearrangements in Chronic Myeloid Leukemia with Complex t(9;22) Using Fluorescence In Situ Hybridization (FISH). J Assoc Genet Technol. 2012; 38(1):5-7.

  8. Primo D, Tabernero MD, Rasillo A, Sayagués JM, Espinosa AB, Chillón MC et al. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: Incidence and underlying genetic abnormalities. Leukemia. 2003 Jun; 17(6):1124-9.

  9. Jiang H, Xue YQ, Pan JL, Zhang J, Dai HP, Wu YF et al. The different signal patterns of two FISH probes in the FISH detection of Ph- positive leukemia and their significance clinical. Zhonghua Yi Xue Chuan Xue Za Zhi. 2010 Apr; 27(2):166-70.

  10. Jain PP, Parihar M, Ahmed R, Abraham A, Vishwabandya A, George B et al. Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis. Indian J Pathol Microbiol. 2012 Sept; 55 (3):347-51.

  11. Wu W, Li JY, Shen YF, Cao XS, Qiu HR, Xu W. The prognostic significance of derivative chromosome 9 deletions in chronic myeloid leukemia. Zhonghua Nei Ke Za Zhi. 2007, 46(5): 386-8.

  12. Vaz de Campos MG,Montesano FT,Rodríguez MM, Chauffaille M de L. Clinical implications of der (9q) deletions detected through dual-fusion fluorescence in situ hybridization in patients with chronic myeloid leukemia. Cancer Genet Cytogenet. 2007 Oct; 178(1):49-56.

  13. Quintás-Cardama A, Kantarjian H, Shan J, Jabbour E, Abruzzo LV, Verstovsek S, et al. Prognostic impact of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia treated with nilotinib or dasatinib. Cancer. 2011 Nov; 117(22): 5085-93.

  14. Castagnetti F, Testoni N, Luatti S, Marzocchi G, Mancini M, Kerim S et al. Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate GINEMA CML working party analysis. J Clin Oncol. 2010; 28:2748-54.

  15. Lim TH, Tien SL, Lim P, Lim A. The incidence and patterns of BCR/ABL rearregements in Chronic Myeloid Leukaemia (CML) using fluorescence in situ Hibridisation (FISH). An Acad Med Singapure. 2005 Oct; 34(9):533-8.




2020     |     www.medigraphic.com